SEC

In the midst of a shaky economic landscape, Braze (BRZE) has managed to not only stay afloat but thrive. TD Cowen's analyst, Derrick Wood, has reaffirmed his Buy rating on Braze's stock, setting a price target of $52.00. This decision is rooted in Braze's impressive revenue growth, which has surpas

In the midst of a contentious election season, a looming threat to seniors' financial stability and healthcare hangs in the balance. Kevin Roberts, leader of Project 2025, has delayed the release of his book detailing significant cuts and changes to Social Security and Medicare/Medicaid until after